BridgeMD
New treatment option for Patients With Heart Failure Undergoing Cardiac Surgery
Official title Telemedically Assisted Optimization for Heart Failure Patients Before Cardiac Surgery to Improve Perioperative Outcome
ClinicalTrials.gov ID: NCT07391683
What this study is testing
- What it's testing
- Patients with heart failure undergoing cardiac surgery face a significantly increased perioperative risk, yet no standardized strategy exists to mitigate this risk effectively. Current preoperative management relies on optimization of medical therapy without a structured prehabilitation approach.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Indication for elective cardiac surgery in the Heart team
- NTproBNP ≥ 1500 ng/L
- ≥ 18 years willing to participate in trial
- Written informed consent
You likely can't join if
- Neuropsychiatric disorders / illnesses (e.g. drug addiction, alcohol abuse) that do not allow adherent participation in the study
- No sufficient ability to measure and transfer data or existing support in the social environment
- no sufficient ability to communicate (language skills, eyesight, hearing)
- Pregnancy
- Chronic kidney disease requiring dialysis
- Planed procedure: heart transplantation (HTX), implant of left ventricular mechanical assist devices (L-VAD)
The study team makes the final eligibility decision.
Where it's taking place
- Innsbruck, Tyrol, Austria
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Innsbruck, Tyrol, Austria. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.